Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,035,260 papers from all fields of science
Search
Sign In
Create Free Account
Calcitriol Topical Product
Known as:
Topical Calcitriol
A topical formulation containing the hormonally active form of vitamin D3, with potential protective activity against chemotherapy-induced alopecia…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Calcitriol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Case of isolated benign primary cutaneous plasmacytosis in a child
J. Ahn
,
Yun‐Seok Yang
,
M. Shin
,
Sung-won Lee
,
N. Kim
Journal of dermatology (Print)
2011
Corpus ID: 1138519
A collection of plasma cells in the skin can represent a broad spectrum of disease entities. Secondary syphilis, primary…
Expand
Highly Cited
2009
Highly Cited
2009
Topical calcitriol protects from UV‐induced genetic damage but suppresses cutaneous immunity in humans
D. Damian
,
Young Jin Kim
,
K. Dixon
,
G. Halliday
,
A. Javeri
,
R. Mason
Experimental Dermatology
2009
Corpus ID: 24821145
Please cite this paper as: Topical calcitriol protects from UV‐induced genetic damage but suppresses cutaneous immunity in humans…
Expand
2004
2004
Treatment of Hailey-Hailey disease with topical calcitriol.
L. Bianchi
,
M. Chimenti
,
A. Giunta
Journal of American Academy of Dermatology
2004
Corpus ID: 9961229
2001
2001
Long‐term safety of topical calcitriol 3 μg g−1 ointment
M. Gerritsen
,
P. V. D. van de Kerkhof
,
A. Langner
British Journal of Dermatology
2001
Corpus ID: 22597480
To assess the topical and systemic safety and tolerance of twice‐daily application of 3 μg g−1 1α25‐dihydroxyvitamin D3…
Expand
Review
2001
Review
2001
Topical calcitriol – studies on local tolerance and systemic safety
E. Rizova
,
M. Corroller
British Journal of Dermatology
2001
Corpus ID: 38734162
Calcitriol 3 μg g−1 ointment (Silkis ointment®, Galderma Laboratories) is a new treatment for psoriasis. Calcitriol is the…
Expand
Highly Cited
1998
Highly Cited
1998
Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
M. Schilli
,
R. Paus
,
A. Menrad
Journal of Investigative Dermatology
1998
Corpus ID: 38574617
Chemotherapy-induced alopecia is thought to result from cytotoxic and apoptosis-related damage to the hair follicle. This study…
Expand
Highly Cited
1997
Highly Cited
1997
Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluation.
J. Reichrath
,
A. Pérez
,
+4 authors
M. Holick
Acta Dermato-Venereologica
1997
Corpus ID: 22058228
The potent calciotropic hormone calcitriol (1,25-dihydroxyvitamin D3, 1,25(OH)2D3) has been shown to be very effective and safe…
Expand
Highly Cited
1996
Highly Cited
1996
Efficacy and safety of topical calcitriol (1,25‐dihydroxyvitamin D3) for the treatment of psoriasis
A. Pèrez
,
Tai C. Chen
,
+4 authors
M. Holick
British Journal of Dermatology
1996
Corpus ID: 24213908
Summary Plaque‐type psoriasis has been successfully treated with topical calcitriol. but there has been no term follow‐up study…
Expand
Highly Cited
1996
Highly Cited
1996
Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
R. Paus
,
M. Schilli
,
B. Handjiski
,
A. Menrad
,
B. Henz
,
P. Płonka
Cancer Research
1996
Corpus ID: 12825554
Using a murine model that mimics chemotherapy-induced alopecia (CIA) in humans particularly well, we show here that in contrast…
Expand
1996
1996
Effect of UVB phototherapy and oral calcitriol (1,25-dihydroxyvitamin D3) on vitamin D photosynthesis in patients with psoriasis.
J. Prystowsky
,
P. J. Muzio
,
Sloane Sevran
,
Thomas L. Clemens
Journal of American Academy of Dermatology
1996
Corpus ID: 24215213
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE